Julien de Salaberry

CEO & Founder, Galen Growth Asia: The Asia HealthTech Builder

Singapore

Changing the world comes in many forms - I am a healthcare change catalyst and evangelist who challenges the status quo in healthcare whilst understanding the world in which healthcare providers and organizations function. I strongly believe that medicine and healthcare are being transformed driven by Deep Tech representing an unprecedented opportunity for better patient outcome in Asia. I am the Founder and CEO of Galen Growth Asia, whose mission it is to build a sustainable and vibrant HealthTech ecosystem across Asia by scaling digital health innovation through industry partnerships.

With over 15 years of experience in healthcare with leading brands including Eli Lilly, Boston Scientific, Baxter, GSK, Merck&Co., I have a deep understanding of organic and inorganic growth in healthcare in both developed and emerging markets. I gained extensive international business experience across Europe, Middle East and Asia.

In 2012, I founded The Propell Group, a boutique venture investor and advisory firm, based in Singapore, which focuses on HealthTech startups and growth companies.

I also co-founded the Global Cancer Research & Commercialisation Fund in 2016 to establish greater collaboration and open innovation between research institutes, research foundations and investors from all corners of the globe. The fund’s goal is to harness technology and business model innovation to deliver superior financial returns and, most importantly, drive better outcomes for cancer patients.

I co-wrote iDisrupted (published in November 2014) which focused on creating an understanding of the IR4's significant technological changes which are just beginning to re-shape our daily lives. I am now co-writing its sequel where we will address how IR4 is changing society.

I am also a regular speaker on HealthTech / Digital Health Innovation and Disruption.